Detalles de la búsqueda
1.
Which clinical research questions are the most important? Development and preliminary validation of the Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network Research Question Importance Tool (ANZMUSC-RQIT).
PLoS One
; 18(3): e0281308, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36930668
2.
Genetic analysis suggests a surface of PAT-4 (ILK) that interacts with UNC-112 (kindlin).
G3 (Bethesda)
; 12(7)2022 07 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35536217
3.
Is acamprosate use in alcohol dependence treatment reflected in improved subjective health status outcomes beyond cognitive behavioural therapy alone?.
J Addict Dis
; 25(4): 49-58, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-17088225
4.
Identification of SUMO modification sites in the base excision repair protein, Ntg1.
DNA Repair (Amst)
; 48: 51-62, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27839712
5.
Nav1.1 modulation by a novel triazole compound attenuates epileptic seizures in rodents.
ACS Chem Biol
; 9(5): 1204-12, 2014 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-24635129
6.
Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
Alcohol Alcohol
; 41(3): 321-7, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16467406
7.
Alcohol dependence: the impact of cognitive behaviour therapy with or without naltrexone on subjective health status.
Aust N Z J Psychiatry
; 38(10): 842-8, 2004 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-15369544
8.
Cognitive behavioural therapy combined with the relapse-prevention medication acamprosate: are short-term treatment outcomes for alcohol dependence improved?
Aust N Z J Psychiatry
; 36(5): 622-8, 2002 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-12225445
Resultados
1 -
8
de 8
1
Próxima >
>>